Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook - Street Insider

Sign Up | Log In | What is SocialPicks?

Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
Mar 12, 2009 03:01 PM UTC

Street Insider

Return	Risk
+9.67%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
CVTX	n/a
KOG	n/a
GE	n/a

Via StreetInsider.com News Articles:

StreetInsider.com Morning Movers:

Kodiak Oil & Gas (NYSE: KOG) 30% LOWER; reports Q4 loss of $0.37, which may not compare to the analyst estimate of ($0.03).

CV Therapeutics, Inc. (Nasdaq: CVTX) 28% HIGHER; Gilead Sciences, Inc. (Nasdaq: GILD) and CV Therapeutics announced the signing of a definitive agreement pursuant to which Gilead will acquire CV Therapeutics for $20.00 per share in cash through a tender offer and second step merger. MORE

Steel Dynamics, Inc. (Nasdaq: STLD) 20% LOWER; lowers its Q1 EPS
guidance from a gain of $0.05-$0.10 to a loss of $0.40-$0.45, versus
the consensus of $0.10. Click here

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.